The global transdermal drug delivery systems market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for non-invasive treatment methods. The market is also driven by the growing number of patients suffering from skin disorders, which are treated with transdermal drug delivery systems.
The global transdermal drug delivery systems market has been segmented on the basis of type, application and region. Based on type, the fentanyl segment accounted for the largest share in 2018 owing to its high therapeutic efficacy and low side effects profile in comparison with other drugs used for pain management such as morphine or oxycodone. Based on application, OTC segment accounted for the largest share in 2018 due to its wide availability and easy accessibility without any prescription required. Based on region, North America accounted for the largest share in 2018 due to higher adoption rates among patients suffering from chronic diseases such as diabetes mellitus or hypertension coupled with high disposable income levels among consumers residing in this region.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the Transdermal Drug Delivery Systems market.
- Increasing awareness about the benefits of transdermal drug delivery systems over oral medication is also driving the growth of this market.
- The increasing number of new product launches in this segment are also contributing to its growth.
- Increasing demand for transdermal drug delivery systems in emerging markets such as China, India, Brazil, and Mexico are also driving its growth.
Industry Growth Insights published a new data on “Transdermal Drug Delivery Systems Market”. The research report is titled “Transdermal Drug Delivery Systems Market research by Types (Fentanyl, Nitroglycerin, Estradiol, Nicotine, Other), By Applications (OTC, Rx), By Players/Companies Hisamitsu, Mylan, GSK, Novartis, Teve(Actavis), Johnson & Johnson, UCB, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum Company, Laboratoires Genevrier”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Drug Delivery Systems Market Research Report
By Type
Fentanyl, Nitroglycerin, Estradiol, Nicotine, Other
By Application
OTC, Rx
By Companies
Hisamitsu, Mylan, GSK, Novartis, Teve(Actavis), Johnson & Johnson, UCB, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum Company, Laboratoires Genevrier
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Drug Delivery Systems Market Report Segments:
The global Transdermal Drug Delivery Systems market is segmented on the basis of:
Types
Fentanyl, Nitroglycerin, Estradiol, Nicotine, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
OTC, Rx
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hisamitsu
- Mylan
- GSK
- Novartis
- Teve(Actavis)
- Johnson & Johnson
- UCB
- Teikoku Seiyaku
- Bayer
- Lingrui
- Sanofi
- Qizheng
- Endo
- Huarun 999
- Haw Par
- Nichiban
- Mentholatum Company
- Laboratoires Genevrier
Highlights of The Transdermal Drug Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fentanyl
- Nitroglycerin
- Estradiol
- Nicotine
- Other
- By Application:
- OTC
- Rx
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transdermal drug delivery system is a type of medication that is applied to the skin. This system allows drugs to be delivered directly to the bloodstream, bypassing the digestive system. Transdermal systems are often more effective than other forms of medication, because they allow for faster absorption into the body.
Some of the major companies in the transdermal drug delivery systems market are Hisamitsu, Mylan, GSK, Novartis, Teve(Actavis), Johnson & Johnson, UCB, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum Company, Laboratoires Genevrier.
The transdermal drug delivery systems market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transdermal Drug Delivery Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transdermal Drug Delivery Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transdermal Drug Delivery Systems Market - Supply Chain
4.5. Global Transdermal Drug Delivery Systems Market Forecast
4.5.1. Transdermal Drug Delivery Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transdermal Drug Delivery Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transdermal Drug Delivery Systems Market Absolute $ Opportunity
5. Global Transdermal Drug Delivery Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transdermal Drug Delivery Systems Market Size and Volume Forecast by Type
5.3.1. Fentanyl
5.3.2. Nitroglycerin
5.3.3. Estradiol
5.3.4. Nicotine
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transdermal Drug Delivery Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transdermal Drug Delivery Systems Market Size and Volume Forecast by Application
6.3.1. OTC
6.3.2. Rx
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transdermal Drug Delivery Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transdermal Drug Delivery Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transdermal Drug Delivery Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transdermal Drug Delivery Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transdermal Drug Delivery Systems Demand Share Forecast, 2019-2026
9. North America Transdermal Drug Delivery Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transdermal Drug Delivery Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transdermal Drug Delivery Systems Market Size and Volume Forecast by Application
9.4.1. OTC
9.4.2. Rx
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transdermal Drug Delivery Systems Market Size and Volume Forecast by Type
9.7.1. Fentanyl
9.7.2. Nitroglycerin
9.7.3. Estradiol
9.7.4. Nicotine
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transdermal Drug Delivery Systems Demand Share Forecast, 2019-2026
10. Latin America Transdermal Drug Delivery Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transdermal Drug Delivery Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transdermal Drug Delivery Systems Market Size and Volume Forecast by Application
10.4.1. OTC
10.4.2. Rx
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transdermal Drug Delivery Systems Market Size and Volume Forecast by Type
10.7.1. Fentanyl
10.7.2. Nitroglycerin
10.7.3. Estradiol
10.7.4. Nicotine
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transdermal Drug Delivery Systems Demand Share Forecast, 2019-2026
11. Europe Transdermal Drug Delivery Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transdermal Drug Delivery Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transdermal Drug Delivery Systems Market Size and Volume Forecast by Application
11.4.1. OTC
11.4.2. Rx
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transdermal Drug Delivery Systems Market Size and Volume Forecast by Type
11.7.1. Fentanyl
11.7.2. Nitroglycerin
11.7.3. Estradiol
11.7.4. Nicotine
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transdermal Drug Delivery Systems Demand Share, 2019-2026
12. Asia Pacific Transdermal Drug Delivery Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transdermal Drug Delivery Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transdermal Drug Delivery Systems Market Size and Volume Forecast by Application
12.4.1. OTC
12.4.2. Rx
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transdermal Drug Delivery Systems Market Size and Volume Forecast by Type
12.7.1. Fentanyl
12.7.2. Nitroglycerin
12.7.3. Estradiol
12.7.4. Nicotine
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transdermal Drug Delivery Systems Demand Share, 2019-2026
13. Middle East & Africa Transdermal Drug Delivery Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transdermal Drug Delivery Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transdermal Drug Delivery Systems Market Size and Volume Forecast by Application
13.4.1. OTC
13.4.2. Rx
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transdermal Drug Delivery Systems Market Size and Volume Forecast by Type
13.7.1. Fentanyl
13.7.2. Nitroglycerin
13.7.3. Estradiol
13.7.4. Nicotine
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transdermal Drug Delivery Systems Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transdermal Drug Delivery Systems Market: Market Share Analysis
14.2. Transdermal Drug Delivery Systems Distributors and Customers
14.3. Transdermal Drug Delivery Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hisamitsu
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mylan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GSK
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teve(Actavis)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. UCB
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Teikoku Seiyaku
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bayer
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lingrui
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sanofi
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Qizheng
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Endo
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Huarun 999
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Haw Par
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Nichiban
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Mentholatum Company
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Laboratoires Genevrier
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
